Ascendis Pharma A/S to Participate in 40th Annual J.P. Morgan Healthcare Conference

On January 4, 2022 Ascendis Pharma A/S (Nasdaq: ASND) reported that the Company is scheduled to participate in the upcoming 40th Annual J.P. Morgan Healthcare Conference (Press release, Ascendis Pharma, JAN 4, 2022, View Source [SID1234598028]). Company executives will provide a business overview and update on the company’s pipeline programs.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

Schedule Your 30 min Free Demo!

Details

Event 40th Annual J.P. Morgan Healthcare Conference
Location Virtual
Date Monday, January 10, 2022
Time 3:00 p.m.-3:40 p.m. Eastern Time
A live webcast of the event will be available on the Investors & News section of the Ascendis Pharma website at View Source A webcast replay will be available on the site shortly after conclusion of the event and will stay available for 30 days.

Use the contact form at the top or bottom of this page to book a free demo to 1stOncology™, an all inclusive cancer drug development intelligence platform from BioSeeker. The platform provides value in oncology for you in areas such as:

Target scouting
Indication selection & expansion
Combinatorial drug settings
Drug repositioning
First in class analysis
Compound cross over analysis
Competitive analysis
Pathway analysis

and much more...

1stOncology is recognized as a
Top 10 Global Pharma Analytic Provider

Continue your journey with 1stOncology by accessing our Free Leading Cancer Conference Whitepapers, signing up for our Free Weekly Newsletter and requesting a Free Demo to see how we can help you be 1st in Oncology!